Stand Up to Cancer (SU2C) engages the media and entertainment industries in a movement that aims to be “where the end of cancer begins.”
The 2008 telethon that raised over $100 million for cancer research was founded by (pictured L to R) Laura Ziskin, Lisa Paulsen, Kathleen Cobb, Noreen Fraser, Ellen Zifflen, Sherry Lansing, Rusty Robertsen, Sue Schwartz and Katie Couric (not pictured). This program of the Entertainment Industry Foundation accelerates groundbreaking cancer research and brings together the best and the brightest in the cancer community, encouraging collaboration instead of competition. Capitalizing on the unparalleled capabilities of the entertainment industry to galvanize audiences, SU2C promotes public awareness and support through new and traditional media, including a vibrant and informative web site. The scale and skill of its operations and its focus on effective partnerships with real-time results makes SU2C a game-changer in cancer philanthropy, advocacy and research.
The Mass General Cancer Center leads five multi-intuitional “dream teams” to receive a grant from SU2C. The Cancer Center received $15 million to help accelerate and disseminate research being done on the CTC-chip, a microchip-based device for detecting and analyzing circulating tumor cells carried in the bloodstream. The CTC-chip can capture cancer cells — one tumor cell in a billion blood cells — from a small blood sample. The technology has the potential to revolutionize the way oncologists detect, monitor and treat cancers in the future.
